A detailed history of Peak6 Investments LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Peak6 Investments LLC holds 15,000 shares of ARVN stock, worth $387,900. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,000
Previous 7,500 100.0%
Holding current value
$387,900
Previous $199,000 85.43%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$23.66 - $32.73 $70,980 - $98,189
-3,000 Reduced 16.67%
15,000 $369,000
Q2 2024

Aug 13, 2024

BUY
$24.46 - $40.4 $269,060 - $444,400
11,000 Added 157.14%
18,000 $479,000
Q1 2024

May 14, 2024

BUY
$36.38 - $52.31 $254,660 - $366,170
7,000 New
7,000 $288,000
Q2 2022

Aug 12, 2022

SELL
$36.01 - $74.24 $18,869 - $38,901
-524 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$60.27 - $81.57 $31,581 - $42,742
524 New
524 $35,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.38B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.